glp-1 expression receptor signalling promotes β-cell glucose metabolism via mTOR-dependent HIF-1α activation GLP-1 Receptor Agonists in Solid
Description
Bibcode:1987PNAS...84.3434D
Each has completed extensive clinical trials and regulatory evaluation as a final drug product
& Gozen, A
More specifically, orforglipron is a potent partial GLP-1 RA which is biased towards G-protein activation over to -arrestin recruitment at the GLP-1 receptor [23]
Kidney function, as assessed with eGFR (estimated glomerular filtration rate), was calculated with the IDMS traceable MDRD-study equation
Is depression more likely with higher GLP-1 doses
